ストックスクリーナーアプリを入手
33.92
1.60%
0.535
前日終値:
$33.39
開ける：
$34.21
24時間の取引高:
232.96K
Relative Volume:
0.11
時価総額：
$5.42B
収益：
$616.29M
当期純損益:
$447.18M
株価収益率:
12.22
EPS:
2.7771
ネットキャッシュフロー:
$-24.99M
1週間 パフォーマンス:
+1.02%
1か月 パフォーマンス:
+15.90%
6か月 パフォーマンス:
-5.11%
1年 パフォーマンス:
-4.52%
1日の値動き範囲:
$33.55
$34.49
1週間の範囲:
$33.05
$35.33
52週間の値動き範囲:
$25.28
$46.48
Tg Therapeutics Inc Stock (TGTX) Company Profile
名前
Tg Therapeutics Inc
セクター
電話
(212) 554-4484
住所
2 GANSEVOORT STREET, 9TH FLOOR, NEW YORK, NY
Compare TGTX vs VRTX, REGN, ARGX, ALNY, INSM
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TGTX
Tg Therapeutics Inc
|
33.94 | 5.33B | 616.29M | 447.18M | -24.99M | 2.7771 |
VRTX
Vertex Pharmaceuticals Inc
|
437.68 | 109.85B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
765.09 | 80.38B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
774.84 | 47.60B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.00 | 42.63B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
159.46 | 35.19B | 606.42M | -1.28B | -997.58M | -6.403 |
Tg Therapeutics Inc Stock (TGTX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-10-06 | 再開されました | H.C. Wainwright | Buy |
| 2025-07-10 | 再開されました | Goldman | Neutral |
| 2024-10-29 | 開始されました | TD Cowen | Buy |
| 2023-08-02 | アップグレード | Goldman | Sell → Neutral |
| 2023-06-26 | 再開されました | Jefferies | Buy |
| 2022-05-20 | 開始されました | BofA Securities | Underperform |
| 2022-02-23 | 繰り返されました | B. Riley Securities | Buy |
| 2021-11-15 | ダウングレード | Goldman | Neutral → Sell |
| 2021-04-20 | 開始されました | Goldman | Neutral |
| 2021-04-19 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-09-01 | 開始されました | JP Morgan | Overweight |
| 2020-08-11 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-06-05 | 開始されました | Evercore ISI | Outperform |
| 2020-01-17 | 繰り返されました | H.C. Wainwright | Buy |
| 2019-11-27 | 再開されました | B. Riley FBR | Buy |
| 2019-02-06 | 再開されました | Jefferies | Buy |
| 2018-09-25 | ダウングレード | Raymond James | Strong Buy → Outperform |
| 2018-03-09 | 繰り返されました | B. Riley FBR, Inc. | Buy |
| 2017-12-01 | 再開されました | B. Riley FBR, Inc. | Buy |
| 2017-11-14 | 再開されました | H.C. Wainwright | Buy |
| 2017-04-25 | 開始されました | Jefferies | Buy |
| 2017-03-06 | 繰り返されました | FBR & Co. | Outperform |
| 2016-10-06 | 再開されました | Brean Capital | Buy |
| 2016-05-27 | 開始されました | SunTrust | Buy |
| 2015-12-01 | 開始されました | FBR Capital | Outperform |
| 2015-09-09 | 開始されました | Raymond James | Strong Buy |
| 2015-08-12 | 再開されました | H.C. Wainwright | Buy |
| 2015-06-19 | 繰り返されました | Brean Capital | Buy |
| 2014-12-11 | 繰り返されました | ROTH Capital | Buy |
| 2014-12-10 | 繰り返されました | ROTH Capital | Buy |
すべてを表示
Tg Therapeutics Inc (TGTX) 最新ニュース
Fed Meeting: Can TG Therapeutics Inc expand into new marketsMarket Trend Report & Daily Momentum Trading Reports - baoquankhu1.vn
Gains Recap: Is TG Therapeutics Inc undervalued by DCF analysis - baoquankhu1.vn
TG Therapeutics, Inc. (NASDAQ:TGTX) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
TGTX PE Ratio & Valuation, Is TGTX Overvalued - intellectia.ai
TG Therapeutics Inc (NASDAQ:TGTX): An Affordable Growth Stock with Strong Momentum - ChartMill
TG Therapeutics, Inc. (TGTX) Stock forecasts - Yahoo Finance UK
TG THERAPEUTICS INC (1TGTX.MI) Balance Sheet - ca.finance.yahoo.com
TG Therapeutics, Inc. (TGTX) Stock Price, News, Quote & History - Yahoo! Finance Canada
TG Therapeutics Inc. (TGTX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
TGTX Stock Price, Quote & Chart | TG THERAPEUTICS INC (NASDAQ:TGTX) - ChartMill
(TGTX) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
TG Therapeutics, Inc. (TGTX) Stock Forecasts - Yahoo Finance
TG Therapeutics: Briumvi Performance Aiding Upside, Buybacks Limiting Downside (TGTX) - Seeking Alpha
Analyst Calls: Is TG Therapeutics Inc undervalued by DCF analysis2026 Reactions & Long-Term Safe Investment Plans - baoquankhu1.vn
TG Therapeutics, Inc. $TGTX Shares Bought by JPMorgan Chase & Co. - MarketBeat
TG Therapeutics stock price forecast: overbought readings persist as TGTX consolidates below SMA-200 - Traders Union
Nordea Investment Management AB Buys Shares of 79,696 TG Therapeutics, Inc. $TGTX - MarketBeat
TG Therapeutics, Inc. $TGTX Shares Purchased by Assenagon Asset Management S.A. - MarketBeat
Vanguard disaggregates holdings after realignment — TG Therapeutics (TGTX) - Stock Titan
TG THERAPEUTICS INC (1TGTX.MI) Stock Major Holders - ca.finance.yahoo.com
TG Therapeutics announces $100M share buyback program - MSN
US$750 Million Credit Facility Could Be A Game Changer For TG Therapeutics (TGTX) - simplywall.st
A Look At TG Therapeutics (TGTX) Valuation After New US$750 Million Credit Facility - Yahoo Finance
1,922,410 Shares in TG Therapeutics, Inc. $TGTX Acquired by Congress Asset Management Co. - marketbeat.com
TG Therapeutics (TGTX) reports financial results for Q4 and full year 2025 - MSN
Day Trade: Is TG Therapeutics Inc still a buy after recent gains2026 Review & Stepwise Trade Execution Plans - baoquankhu1.vn
CapEx per share of TG Therapeutics, Inc. – MIL:1TGTX - TradingView
TG Therapeutics Credit Deal And Valuation Gap Catch Investor Attention - simplywall.st
TG Therapeutics Files Procedural 8-K on Financial Obligation - The Globe and Mail
(TGTX) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
TG Therapeutics, Inc. (TGTX) Enters $750 Million Term Loan Agreement – SEC 8-K Filing Summary - Minichart
Form 8K TG Therapeutics Inc For: 20 March By Investing.com - Investing.com Canada
Form 8K TG Therapeutics Inc For: 20 March - Investing.com
TG Therapeutics, Inc. Enters into First Amendment Agreement for $750 Million Term Loan Facility and $250 Million Uncommitted Additional Facility - marketscreener.com
TG Therapeutics (TGTX) secures $750M 2026 Term Loan maturing 2031 - Stock Titan
TG Therapeutics, Inc. (NASDAQ:TGTX) Q4 2025 earnings call transcript - MSN
TG Therapeutics (TGTX) Secures $750 Million Credit Facility - GuruFocus
TG Therapeutics secures $750M credit facility with Blue Owl By Investing.com - Investing.com India
TG Therapeutics board expands share repurchase program to $300M - TipRanks
TG Therapeutics secures $750M credit facility with Blue Owl - investing.com
TG Therapeutics (TGTX) Secures $750M Credit Facility, Expands Sh - GuruFocus
TG Therapeutics Receives $500 Million in New Capital From Blue Owl, Increases Share Buyback - marketscreener.com
TG Therapeutics secures an additional $500 million in non-dilutive capital from Blue Owl and expands share repurchase program to $300 million - marketscreener.com
TG Therapeutics Secures An Additional $500 Million In Non-Dilutive Capital From Blue Owl And Expands Share Repurchase Program To $300 Million - TradingView
TG Therapeutics Secures an Additional $500 Million in Non-Dilutive Capital from Blue Owl and Expands Share Repurchase Program to $300 Million - The Manila Times
TG Therapeutics Secures an Additional $500 Million in - GlobeNewswire
TG Therapeutics Secures an Additional $500 Million in Non-Dilutive Capital From Blue Owl and Expands Share Repurchase Program to $300 Million - 富途牛牛
Penn Capital Management Company LLC Grows Stock Position in TG Therapeutics, Inc. $TGTX - MarketBeat
Is the options market predicting a spike in TG Therapeutics stock? - MSN
TG Therapeutics Analysis: Strong Clinical Data Boost Briumvi Prospects - timothysykes.com
TG Therapeutics (NASDAQ:TGTX) Shares Up 7.9%Here's What Happened - MarketBeat
Tg Therapeutics Inc (TGTX) 財務データ
収益
当期純利益
現金流量
EPS
0.21%
2.58%
大文字化:
|
ボリューム (24 時間):